GlaxoSmithKline Antitrust Probe Dropped by EU Commission

The European Commission said it ended an antitrust probe into GlaxoSmithKline Plc over possible collusion to keep cheaper copies of medicines off the market after a complaint against the company was withdrawn.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.